Contents Volume 14 · Issue 6 · 2020. Pages 689-819 13 articles
REVIEW
Precision medicine in acute lymphoblastic leukemia
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 689-700 doi:10.1007/s11684-020-0759-8
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 701-710 doi:10.1007/s11684-020-0763-z
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 711-725 doi:10.1007/s11684-020-0808-3
Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 726-745 doi:10.1007/s11684-020-0746-0
RESEARCH ARTICLE
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 746-751 doi:10.1007/s11684-020-0822-5
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 752-759 doi:10.1007/s11684-020-0813-6
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 760-775 doi:10.1007/s11684-020-0803-8
Clinical manifestations and pathogen characteristics in children admitted for suspected COVID-19
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 776-785 doi:10.1007/s11684-020-0820-7
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 786-791 doi:10.1007/s11684-020-0751-3
Cerebral regional and network characteristics in asthma patients: a resting-state fMRI study
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 792-801 doi:10.1007/s11684-020-0745-1
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 802-810 doi:10.1007/s11684-019-0723-7
COMMENTARY
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 811-815 doi:10.1007/s11684-020-0740-6
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 816-819 doi:10.1007/s11684-020-0823-4